21 jun: Pandora/SHB: Pilen peger mod svagt andet kvartal
21 jun: Aktier/åbning: Novo holder C20 oven vande
21-06-2012 09:05:00

Invensys Rejects Emerson Approach, Talks End

Relateret indhold

LONDON--Invensys PLC (ISYS.LN) Thursday confirmed it had received a takeover approach from U.S. industrial conglomerate Emerson Electric Co. (EMR), but the maker of rail signaling and industrial automation systems said it had ended the talks.

It said the approach from Emerson was "highly preliminary" and that there are no other discussions taking place in relation to an offer for the whole group. Invensys said it had also been in "highly preliminary discussions" with third parties for parts of the group, but they have also ended.

It said it "regularly assesses the value of its portfolio of businesses' both as part of its "strategic planning process and in response to expressions of interest in relation to certain parts of the group".

A report Wednesday said Emerson is mainly interested in Invensys's Foxboro unit, which makes meters and control systems, and not the British company's rail unit, although Emerson could consider a deal for the whole of Invensys to get control of Foxboro.

Advisers to Invensys have spoken to companies including Siemens AG (SI) and General Electric Co. (GE) about a sale of some or all of its businesses since Emerson's approach, the Bloomberg report said, citing people familiar with the situation.

Invensys shares closed Wednesday at 257 pence, valuing the company at GBP2.09 billion. The FTSE 100 stock has risen 22% this calendar year.

Write to Simon Zekaria at simon.zekaria@dowjones.com

(END) Dow Jones Newswires

June 21, 2012 03:05 ET (07:05 GMT)

Copyright (c) 2012 Dow Jones & Company, Inc.

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
Ingen indlæg

Fondsbørsmeddelelser

Sanofi vil smide Medivations bestyrelse på porten

25-05-2016 13:38:02
Det franske medicinalselskab Sanofi, der konkurrerer med blandt andet danske Novo Nordisk, vil have skiftet bestyrelsen i amerikanske Medivation ud for at få en..

Aktier/middag: Novo fortsat i føretrøjen efter amerikansk ja

25-05-2016 11:38:16
Novo Nordisk ligger for anden dag i streg som nummer et i C20 Cap-indekset på Københavns Fondsbørs. Onsdag middag fortsætter medicinalgigantens aktier med at væ..

Aktier/tendens: Entydig positiv start på dagens handel i sigte

25-05-2016 08:44:15
Pilen peger entydigt i positiv retning på det danske aktiemarked onsdag morgen.En stærk afslutning på det amerikanske aktiemarked er fulgt op at solide stigning..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
Novo/Sydbank: Xultophy står umiddelbart stærkere end Lixilan
2
Genmab: Darzalex-salg dykkede med knap 9 pct. i april - NY
3
Aktier/middag: Novo fortsat i føretrøjen efter amerikansk ja
4
Onsdagens aktier: Vestas med i toppen på måske-ordre til Laos
5
Vestas er foretrukken leverandør til kæmpeprojekt i Laos - NY

Relaterede aktiekurser

General Electric Co 30,09 0,8% Stigning i aktiekurs
Emerson Electric Co 52,09 1,8% Stigning i aktiekurs
Siemens AG 103,40 0,0% Aktiekurs uændret
Gen.Electric COM STK USD.. 27,07 42,5% Stigning i aktiekurs
GEN Elec 30,00 3,3% Stigning i aktiekurs
General Electric 27,10 1,5% Stigning i aktiekurs
Siemens 96,95 2,1% Stigning i aktiekurs

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Copyright Euroinvestor A/S 2016  Disclaimer Privatlivspolitik
Aktieinformation leveres af Interactive Data.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
26. maj 2016 00:42:33
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20160525.2 - EUROWEB4 - 2016-05-26 00:42:33 - 2016-05-26 00:42:33 - 1 - Website: OKAY

Når du besøger Euroinvestor.dk accepterer du, at der anvendes cookies, som vi og vores samarbejdspartnere benytter til funktionalitet, statistik og markedsføring. Læs mere om cookies på Euroinvestor.dk her

x